This present study was consistent with the reports from earlier studies that treatment with salvianolic acid A, lutein, and betalain inhibited the PI3K/Akt/mTOR signaling pathway resulting in the inhibition of NSCLC [43, 45, 46]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.